药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Anisindione
Ixekizumab
The risk or severity of adverse effects can be increased when Apremilast is combined with Ixekizumab.
Anisindione
Tepoxalin
The risk or severity of adverse effects can be increased when Apremilast is combined with Tepoxalin.
Anisindione
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Apremilast is combined with Antilymphocyte immunoglobulin (horse).
Anisindione
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Apremilast is combined with Peginterferon beta-1a.
Anisindione
Tixocortol
The risk or severity of adverse effects can be increased when Apremilast is combined with Tixocortol.
Anisindione
Dinutuximab
The risk or severity of adverse effects can be increased when Apremilast is combined with Dinutuximab.
Anisindione
Blinatumomab
The risk or severity of adverse effects can be increased when Apremilast is combined with Blinatumomab.
Anisindione
Vedolizumab
The risk or severity of adverse effects can be increased when Apremilast is combined with Vedolizumab.
Anisindione
Obinutuzumab
The risk or severity of adverse effects can be increased when Apremilast is combined with Obinutuzumab.
Anisindione
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Apremilast is combined with Dimethyl fumarate.
Anisindione
Carfilzomib
The risk or severity of adverse effects can be increased when Apremilast is combined with Carfilzomib.
Anisindione
Belimumab
The risk or severity of adverse effects can be increased when Apremilast is combined with Belimumab.
Anisindione
Eribulin
The risk or severity of adverse effects can be increased when Apremilast is combined with Eribulin.
Anisindione
Wortmannin
The risk or severity of adverse effects can be increased when Apremilast is combined with Wortmannin.
Anisindione
Pralatrexate
The risk or severity of adverse effects can be increased when Apremilast is combined with Pralatrexate.
Anisindione
Belatacept
The risk or severity of adverse effects can be increased when Apremilast is combined with Belatacept.
Anisindione
Abetimus
The risk or severity of adverse effects can be increased when Apremilast is combined with Abetimus.
Anisindione
Mepolizumab
The risk or severity of adverse effects can be increased when Apremilast is combined with Mepolizumab.
Anisindione
Human interferon omega-1
The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Apremilast.
Anisindione
Briakinumab
The risk or severity of adverse effects can be increased when Briakinumab is combined with Apremilast.